0001415889-23-016827.txt : 20231221 0001415889-23-016827.hdr.sgml : 20231221 20231221162629 ACCESSION NUMBER: 0001415889-23-016827 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231219 FILED AS OF DATE: 20231221 DATE AS OF CHANGE: 20231221 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Megna Michael R CENTRAL INDEX KEY: 0001464583 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38492 FILM NUMBER: 231505636 MAIL ADDRESS: STREET 1: 1050 HINGHAM STREET CITY: ROCKLAND STATE: MA ZIP: 02370 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Kiniksa Pharmaceuticals, Ltd. CENTRAL INDEX KEY: 0001730430 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: D0 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: CLARENDON HOUSE STREET 2: 2 CHURCH STREET CITY: HAMILTON STATE: D0 ZIP: HM11 BUSINESS PHONE: 7814399100 MAIL ADDRESS: STREET 1: CLARENDON HOUSE STREET 2: 2 CHURCH STREET CITY: HAMILTON STATE: D0 ZIP: HM11 4 1 form4-12212023_091222.xml X0508 4 2023-12-19 0001730430 Kiniksa Pharmaceuticals, Ltd. KNSA 0001464583 Megna Michael R C/O KINIKSA PHARMACEUTICALS, LTD. CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM 11 BERMUDA false true false false CHIEF ACCOUNTING OFFICER 1 Class A Common Share 2023-12-19 4 M 0 9316 13.88 A 26321 D Class A Common Share 2023-12-19 4 S 0 9316 19.13 D 17005 D Share Option 13.88 2023-12-19 4 M 0 9316 0 D 2028-08-05 Class A Common Share 9316 20684 D This transaction was effected pursuant to a Rule 10b5-1 plan executed by the reporting person on May 5, 2023. This option is fully vested and exercisable. /s/ Madelyn Zeylikman, Attorney-in-Fact 2023-12-21